- Wells Fargo lowered the price target for Cheniere Energy, Inc. LNG from $236 to $230. Wells Fargo analyst Michael Blum maintained his overweight position. Cheniere Energy shares fell 4.8% to close at $156.55 on Monday.
- RBC Capital has increased the price target for Cogent Communications Holdings, Inc. CCOI from $61 to $69. RBC Capital analyst Bora Lee kept an Outperform rating on the stock. Shares of Cogent Communications fell 0.2% to close at $63.96 on Monday.
- Mizuho raised the price target for Trip.com Group Limited TCOM from $45 to $49. Mizuho analyst James Lee maintained his buy recommendation. Trip.com shares fell 0.3% to close at $38.61 on Monday.
- BTIG lowered the price target for Aclaris Therapeutics, Inc. ACRS from $32 to $29. BTIG analyst Julian Harrison maintained a buy rating. Aclaris Therapeutics shares fell 2.4% to $6.90 in premarket trading.
- Needham cut Cara Therapeutics, Inc. CARA Price target from $26 to $22. Needham analyst Joseph Stringer maintained a buy rating. Cara Therapeutics shares fell 27.6% to $7.25 in premarket trading.
- Barclays raised Ciena Corporation CIEN Price target from $71 to $74. Barclays analyst Tim Long maintained his overweight position. Ciena shares were up 0.7% in premarket trading at $51.25.
- Evercore ISI Group rose Linde plc LIN Price target from $355 to $375. Evercore ISI Group analyst Stephen Richardson maintained an Outperform rating. Linde shares fell 0.9% to $354.83 in premarket trading.
- Atlantic Equities increased Merck & Co., Inc. MRK Price target from $122 to $127. Atlantic Equities analyst Steve Chesney maintained his overweight position. Merck shares rose 0.1% to $111.12 in premarket trading.
- Credit Suisse increased Esperion Therapeutics, Inc. ESPR Price target from $6.5 to $7. Credit Suisse analyst Judah Frommer upgraded the stock to Neutral from Underperform. Esperion Therapeutics shares fell 0.1% to $5.07 in premarket trading.
- Jefferies increased DocuSign, Inc. DOCUMENTARY Price target of $70 to $80….
[ad_2]
Source story
